当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析

共同药业

(300966)

  

流通市值:13.93亿  总市值:20.95亿
流通股本:7666.50万   总股本:1.15亿

共同药业(300966)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润-0.01亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益101206.43万元,未分配利润29189.68万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产291355.26万元,负债190148.82万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入139,216,213.1536,595,592.03365,389,573.73233,822,011.21
营业总成本144,964,043.16573,756,838.18407,868,913.77250,301,029.55
营业利润-4,323,869.32-42,421,941.53-27,240,577.48-10,159,007.58
利润总额-4,383,203.85-45,535,155.39-26,329,041.44-11,343,177.51
净利润-762,780.33-31,656,138.87-16,527,962.21-6,886,936.29
其他综合收益----
综合收益总额-762,780.33-31,656,138.87-16,527,962.21-6,886,936.29
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计872,425,299.25769,997,377.12758,322,380.59983,388,346.9
非流动资产合计2,041,127,263.592,019,882,951.741,938,930,814.431,789,085,468.41
资产总计2,913,552,562.842,789,880,328.862,697,253,195.022,772,473,815.31
流动负债合计827,325,074.65807,687,044.23782,001,090.12808,879,308.25
非流动负债合计1,074,163,156.26967,551,229.64883,811,551.83922,753,788.57
负债合计1,901,488,230.911,775,238,273.871,665,812,641.951,731,633,096.82
归属于母公司股东权益合计922,404,814.76923,137,679.57938,227,543.92947,030,308.03
股东权益合计1,012,064,331.931,014,642,054.991,031,440,553.071,040,840,718.49
负债和股东权益合计2,913,552,562.842,789,880,328.862,697,253,195.022,772,473,815.31
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计107,168,250.73636,351,939.69489,936,789.49270,530,205.75
经营活动现金流出小计135,942,532.26656,940,387.32396,660,429.04236,415,710.67
经营活动产生的现金流量净额-28,774,281.53-20,588,447.6393,276,360.4534,114,495.08
投资活动现金流入小计133,30917,275,865.13103,962.35103,904.42
投资活动现金流出小计82,259,738.98311,613,852.76328,954,297.32177,352,775.7
投资活动产生的现金流量净额-82,126,429.98-294,337,987.63-328,850,334.97-177,248,871.28
筹资活动现金流入小计133,865,714.47780,091,146.66610,668,158.75436,169,889.27
筹资活动现金流出小计37,842,705.97460,687,056.14390,785,187.36140,988,213.94
筹资活动产生的现金流量净额96,023,008.5319,404,090.52219,882,971.39295,181,675.33
汇率变动对现金及现金等价物的影响55,663.29-561,781.531,103,231.521,000,560.77
现金及现金等价物净增加额-14,822,039.723,915,873.73-14,587,771.61153,047,859.9
期末现金及现金等价物余额85,299,993.3100,122,033.0281,618,387.68249,254,019.19
最新报告期:2025-04-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋周豫,乔露阳-0.270.130.462025-04-28
太平洋周豫,乔露阳-0.270.130.462025-04-25
TOP↑